 |
answer text |
<p>The manufacturer of Evorel transdermal patches has confirmed that supplies of all
presentations are currently available. However, they have stated that in some cases
supplies are slightly lower than normal and therefore they are applying restrictions
on orders as a precaution to ensure limited stock is maintained.</p><p>The Department
is aware that the supplier of FemSeven Sequi patches is experiencing long term supply
issues. As a result, they are expected to be out of stock until late 2019. We remain
in regular contact with the company to resolve this as soon as possible.</p><p>Supplies
of other hormone replacement therapy transdermal patches continue to remain available
and patients affected have been advised to discuss these alternative treatment options
with their clinician.</p>
|
 |
